Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile

被引：6
|
作者：
Crawford, ED [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80010 USA
来源：
BJU INTERNATIONAL | 2005年 / 95卷
关键词：
LUTS; BPH; alpha(1)-adrenoceptor antagonists; 5 alpha-reductase inhibitors; efficacy; tolerability; disease progression;
D O I：
10.1111/j.1464-410X.2005.05484.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [41] Update in the Use of Botulinum Toxin for the Treatment of Benign Prostatic Hyperplasia/ Lower Urinary Tract Symptoms
    Yokoyama T.
    Chuang Y.-C.
    Chancellor M.B.
    Current Bladder Dysfunction Reports, 2013, 8 (2) : 174 - 179
  • [42] Identifying patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) at risk for progression
    Jiménez-Cruz, F
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 6 - 12
  • [43] Role of calcium channel blockers in lower urinary tract symptoms in benign prostatic hyperplasia: a literature review
    Iheanacho, Chinonyerem O.
    Okwesilieze, Chikezie N.
    Eyong, Abiodun K.
    AFRICAN JOURNAL OF UROLOGY, 2022, 28 (01)
  • [44] Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia
    De Nunzio, Cosimo
    Giglio, Simona
    Stoppacciaro, Antonella
    Gacci, Mauro
    Cirombella, Roberto
    Luciani, Emidio
    Tubaro, Andrea
    Vecchione, Andrea
    ONCOTARGET, 2017, 8 (31) : 50904 - 50910
  • [45] Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction
    Brock, Gerald
    Broderick, Gregory
    Roehrborn, Claus G.
    Xu, Lei
    Wong, David
    Viktrup, Lars
    BJU INTERNATIONAL, 2013, 112 (07) : 990 - 997
  • [46] Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment
    Lerner, Lori B.
    McVary, Kevin T.
    Barry, Michael J.
    Bixler, Brooke R.
    Dahm, Philipp
    Das, Anurag Kumar
    Gandhi, Manhar C.
    Kaplan, Steven A.
    Kohler, Tobias S.
    Martin, Leslie
    Kellogg Parsons, J.
    Roehrborn, Claus G.
    Stoffel, John T.
    Welliver, Charles
    Wilt, Timothy J.
    JOURNAL OF UROLOGY, 2021, 206 (04): : 818 - 826
  • [47] Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention
    Nickel, J. Curtis
    Roehrborn, Claus G.
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    Moreira, Daniel M.
    JOURNAL OF UROLOGY, 2016, 196 (05): : 1493 - 1498
  • [48] Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence
    Carrero-Lopez, V. M.
    Cozar-Olmo, J. M.
    Minana-Lopez, B.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (05): : 288 - 294
  • [49] Editorial comment: Treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Tammela, Teuvo L. J.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (02) : 90 - 91
  • [50] Lower urinary tract symptoms suggestive of benign prostatic obstruction: How can clinical expertise contribute to rational management?
    Stoevelaar, HJ
    McDonnell, J
    Bosch, JLHR
    Kahan, JP
    EUROPEAN UROLOGY, 2001, 39 : 13 - 19
12345